Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-28

Clinical Trial Update: Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle Hypertrophy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating botulinum toxin type A (BOTOX) for treatment of masseter muscle hypertrophy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Masseter Muscle Hypertrophy | Phase 2 | Status: COMPLETED | Results posted: 2019-05-28